<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Osteoarthritis.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:30:17 GMT -->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<meta name="Language" content="es">
<meta name="ContentID" content="1049006">
<meta name="Category" content="Concern">
<meta name="Article" content="Osteoarthritis">
<title>Artrosis-Referencias</title>
<link type="text/css" rel="stylesheet" href="../Styles/hnqrHtml.css">
<base target="_self">
</head>
<body>
<div id="Article-Title" class="Article-Title"><a name="Article-Title"></a> 

<p class="Article-Title">Artrosis</p>
</div>

<div id="Reference-List" class="Reference-List">
<p class="Reference-Autofill"><a href="Osteoarthritis.htm">Volver al
art&#237;culo.</a></p>

<h3>Referencias para el art&#237;culo</h3>

<ol class="Reference-List">
<li class="Ref">Warmbrand M. <em>How Thousands of My Arthritis Patients Regained Their
Health.</em> New York: Arco Publishing, 1974.</li>

<li class="Ref">Childers NF. A relationship of arthritis to the solanaceae (nightshades). <em>
J Internat Acad Pre Med</em> 1982;Nov:31&#8211;7.</li>

<li class="Ref">Childers NF, Margoles MS. An apparent relation of nightshades (Solanaceae) to
arthritis. <em>J Neurol Orthop Med Surg</em> 1993;14:227&#8211;31.</li>

<li class="Ref">Taylor MR. Food allergy as an etiological factor in arthropathies: a survey.
<em>J Internat Acad Prev Med</em> 1983;8:28&#8211;38 [review].</li>

<li class="Ref">Felson DT, Zhang Y, Anthony JM, et al. Weight loss reduces the risk for
symptomatic knee osteoarthritis in women. The Framingham Study. <em>Ann Intern Med</em>
1992;116:535&#8211;9.</li>

<li class="Ref">Felson DT, Zhang Y, HanNan MT, et al. Risk factors for incident radiographic
knee osteoarthritis in the elderly: the Framingham Study. <em>Arthritis Rheum</em>
1997;40:728&#8211;33.</li>

<li class="Ref">Altman RD, Lozada CJ. Practice guidelines in the management of osteoarthritis.
<em>Osteoarthritis Cartilage</em> 1998;6(Suppl A):22&#8211;4 [review].</li>

<li class="Ref">Tapadinhas MJ, Rivera IC, Bignamini AA. Oral glucosamine sulphate in the
management of arthrosis: report on a multi-centre open investigation in Portugal. <em>
Pharmtherapeutica</em> 1982;3:157&#8211;68.</li>

<li class="Ref">Giordano N, Nardi P, Senesi M, et al. The efficacy and safety of glucosamine
sulfate in the treatment of gonarthritis. <em>Clin Ter</em> 1996;147:99&#8211;105.</li>

<li class="Ref">D&#8217;Ambrosio E, Casa B, Bompani G, et al. Glucosamine sulphate: a
controlled clinical investigation in arthrosis. <em>Pharmatherapeutica</em>
1981;2(8):504&#173;8.</li>

<li class="Ref">Crolle G, DiEste E. Glucosamine sulfate for the management of arthrosis. <em>
Curr Ther Res</em> 1980;7:104&#8211;9.</li>

<li class="Ref">Qiu GX, Gao SN, Giacovelli G, et al. Efficacy and safety of glucosamine
sulfate versus ibuprofen in patients with knee osteoarthritis. <em>Arzneimittelforschung</em>
1998;48:469&#8211;74.</li>

<li class="Ref">Reichelt A, F&#246;rster KK, Fischer M, et al. Efficacy and safety of
intramuscular glucosamine sulfate in osteoarthritis of the knee. <em>
Arzneimittelforschung</em> 1994;44:75&#8211;80.</li>

<li class="Ref">Drovanti A, Bignamini AA, Rovati AL. Therapeutic activity of oral glucosamine
sulfate in osteoarthritis: a placebo&#173;controlled double&#173;blind investigation. <em>Clin
Ther</em> 1980;3(4):260&#8211;72.</li>

<li class="Ref">Vaz AL. Double-blind clinical evaluation of the relative efficacy of ibuprofen
and glucosamine sulphate in the management of osteoarthritis of the knee in out&#173;patients.
<em>Curr Med Res Opin</em> 1982;8(3):145&#8211;9.</li>

<li class="Ref">Pujalte JM, Llavore EP, Ylescupidez FR. Double-blind clinical evaluation of
oral glucosamine sulphate in the basic treatment of osteoarthrosis. <em>Curr Med Res Opin</em>
1980;7(2):110&#8211;4.</li>

<li class="Ref">Rindone RP. Randomized controlled trial of glucosamine for treating
osteoarthritis of the knee. <em>West J Med</em> 2000;172:91&#8211;4.</li>

<li class="Ref">Reginster JY, Deroisy R, Rovati L, et al. Long-term effects of glucosamine
sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. <em>
Lancet</em> 2001;357:251&#8211;6.</li>

<li class="Ref">Houpt JB, McMillan R, Wein C, Paget-Dellio SD. Effect of glucosamine
hydrochloride in the treatment of pain of osteoarthritis of the knee. <em>J Rheumatol</em>
1999;26:2423&#8211;30.</li>

<li class="Ref">Kerzberg EM, Roldan EJA, Castelli G, Huberman ED. Combination of
glycosaminoglycans and acetylsalicylic acid in knee osteoarthritis. <em>Scand J Rheum</em>
1987;16:377.</li>

<li class="Ref">Baici A, H&#246;rler D, Moser B, et al. Analysis of glycosaminoglycans in
human serum after oral administration of chondroitin sulfate. <em>Rheumatol Int</em>
1992;12:81&#8211;8.</li>

<li class="Ref">Kerzberg EM, Rold&#225;n EJA, Castelli G, Huberman ED. Combination of
glycosaminoglycans and acetylsalicylic acid in knee osteoarthrosis. <em>Scand J Rheumatol</em>
1987;16:377&#8211;80.</li>

<li class="Ref">Rovetta G. Galactosaminoglycuronoglycan sulfate (Matrix) in therapy of
tibiofibular osteoarhtirits of the knee. <em>Drugs Exptl Clin Res</em>
1991;17:53&#8211;7.</li>

<li class="Ref">Conte A, Volpi N, Palmieri L, et al. Biochemical and pharmacokinetic aspects
of oral treatment with chondroitin sulfate. <em>Arzneimittelforschung</em>
1995;45:918&#8211;25.</li>

<li class="Ref">Ronca F, Palmieri L, Panicucci P, Ronca G. Anti-inflammatory active of
chondroitin sulfate. <em>Osteoarthritis Cartilage</em> 1998;6(Suppl A):14&#8211;21.</li>

<li class="Ref">Uebelhart D, Thonar EJ, Delmas PD, et al. Effects of oral chondroitin sulfate
on the progression of knee osteoarthritis: a pilot study. <em>Osteoarthritis Cartilage</em>
1998;6(Suppl A):39&#8211;46.</li>

<li class="Ref">Verbruggen G, Goemaere S, Veys EM. Chondroitin sulfate: S/DMOAD
(structure/disease modifying anti-osteoarthritis drug) in the treatment of finger joint OA.
<em>Osteoarthritis Cartilage</em> 1998;6(Suppl A):37&#8211;8.</li>

<li class="Ref">Bucsi L, Po&#243;r G. Efficacy and tolerability of oral chondroitin sulfate as
a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee
osteoarthritis. <em>Osteoarthritis Cartilage</em> 1998;6(Suppl A):31&#8211;6.</li>

<li class="Ref">Bourgeois P, Chales G, Dehais J, et al. Efficacy and tolerability of
chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3X400 mg/day vs placebo. <em>
Osteoarthritis Cartilage</em> 1998;6(Suppl A):25&#8211;30.</li>

<li class="Ref">Pipitone V, Ambanelli U, Cervini C, et al. A multicenter, triple-blind study
to evaluate galactosaminoglucuronoglycan sulfate versus placebo in patients with femorotibial
gonarthritis. <em>Curr Ther Res</em> 1992;52:608&#8211;38.</li>

<li class="Ref">Bazi&#232;res B, Loyau G, Menk&#232;s CJ, et al. Le chondro&#239;tine sulfate
dans le traitement de la gonarthrose et de la coxarthrose. <em>Rev Rhum Mal
Ost&#233;oartic</em> 1992;59:466&#8211;72 [in French].</li>

<li class="Ref">Conrozier T, Vignon E. Die Wirkung von Chondroitinsulfat bei der Behandlung
der H&#252;ft Gelenksarthrose. Eine Doppelblindstudie gegen Placebo. <em>Litera
Rheumatologica</em> 1992;14:69&#8211;75 [in German].</li>

<li class="Ref">L&#8217;Hirondel JL. Klinische Doppelblind-Studie mit oral verabreichtem
Chondroitinsulfat gegen Placebo bei der tibiofermoralen Gonarthrose (125 Patienten). <em>
Litera Rheumatologica</em> 1992;14:77&#8211;82 [in German].</li>

<li class="Ref">Morreale P, Manopulo R, Galati M, et al. Comparison of the antiinflammatory
efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis.
<em>J Rheumatol</em> 1996;23:1385&#8211;91.</li>

<li class="Ref">Leeb BF, Petera P, Neumann K. Results of a multicenter study of chondroitin
sulfate (Condrosulf) use in arthroses of the finger, knee and hip joints. <em>Wien Med
Wochenschr</em> 1996;146:609&#8211;14.</li>

<li class="Ref">Bourgeois P, Chales G, Dehais J, et al. Efficacy and tolerability of
chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3X400 mg/day vs placebo. <em>
Osteoarthritis Cartilage</em> 1998;6(Suppl A):25&#8211;30.</li>

<li class="Ref">Schumacher HR. Osteoarthritis: the clinical picture, pathogenesis, and
management with studies on a new therapeutic agent, S-adenosylmethionine. <em>Am J Med</em>
1987;83(Suppl 5A):1&#8211;4 [review].</li>

<li class="Ref">Harmand MF, Vilamitjana J, Maloche E, et al. Effects of S-adenosylmethionine
on human articular chondrocyte differentiation: an in vitro study. <em>Am J Med</em>
1987;83(Suppl 5A):48&#8211;54.</li>

<li class="Ref">Berger R, Nowak H. A new medical approach to the treatment of osteoarthritis.
Report of an open phase IV study with ademetionine (Gumbaral). <em>Am J Med</em>
1987;83:84&#8211;8.</li>

<li class="Ref">Domljan Z, Vrhovac B, Durrigl T, Pucar I. A double-blind trial of ademetionine
vs naproxen in activated gonarthrosis. <em>Int J Clin Pharmacol Ther Toxicol</em>
1989;27:329&#8211;33.</li>

<li class="Ref">M&#252;ller-Fassbender H. Double-blind clinical trial of S-adenosylmethionine
in versus ibuprofen in the treatment of osteoarthritis. <em>Am J Med</em> 1987;83(Suppl
5A):81&#8211;3.</li>

<li class="Ref">Vetter G. Double-blind comparative clinical trial with S-adenosylmethionine
and indomethacin in the treatment of osteoarthritis. <em>Am J Med</em> 1987;83(Suppl
5A):78&#8211;80.</li>

<li class="Ref">Maccagno A. Double-blind controlled clinical trial of oral
S-adenosylmethionine versus piroxicam in knee osteoarthritis. <em>Am J Med</em> 1987;83(Suppl
5A):72&#8211;7.</li>

<li class="Ref">Caruso I, Pietrogrande V. Italian double-blind multicenter study comparing
S-adenosylmethionine, naproxen, and placebo in the treatment of degenerative joint disease.
<em>Am J Med</em> 1987;83(Suppl 5A):66&#8211;71.</li>

<li class="Ref">Marcolongo R, Giordano N, Colombo B, et al. Double-blind multicentre study of
the activity of s-adenosyl-methionine in hip and knee osteoarthritis. <em>Curr Ther Res</em>
1985;37:82&#8211;94.</li>

<li class="Ref">Glorioso S, Todesco S, Mazzi A, et al. Double-blind multicentre study of the
activity of S-adenosylmethionine in hip and knee osteoarthritis. <em>Int J Clin Pharmacol
Res</em> 1985;5:39&#8211;49.</li>

<li class="Ref">Montrone F, Fumagalli M, Sarzi-Puttini P, et al. Double-blind study of
S-adenosyl-methionine versus placebo in hip and knee arthrosis. <em>Clin Rheumatol</em>
1985;4:484&#8211;5.</li>

<li class="Ref">Konig B. A long-term (two years) clinical trial with S-adenosylmethionine for
the treatment of osteoarthritis. <em>Am J Med</em> 1987;83:89&#8211;94.</li>

<li class="Ref">Bradley JD, Flusser D, Katz BP, et al. A randomized, double blind, placebo
controlled trial of intravenous loading with S-adenosylmethionine (SAM) followed by or SAM
therapy in patients with knee osteoarthritis. <em>J Rheumatol</em> 1994;21:905&#8211;11.</li>

<li class="Ref">Di Padova C. S-adenosylmethionine in the treatment of osteoarthritis. Review
of the clinical studies. <em>Am J Med</em> 1987;83:60&#8211;5 [review].</li>

<li class="Ref">McAlindon TE, Jacques P, Zhang Y. Do antioxidant micronutrients protect
against the development and progression of knee osteoarthritis? <em>Arthrit Rheum</em>
1996;39:648&#8211;56.</li>

<li class="Ref">Machtey I, Ouaknine L. Tocopherol in osteoarthritis: a controlled pilot study.
<em>J Am Geriatr Soc</em> 1978;25(7):328&#8211;30.</li>

<li class="Ref">Blankenhorn G. Klinische Wirtsamkeit von Spondyvit (vitamin E) bei aktiverten
arthronsen. <em>Z Orthop</em> 1986;124:340&#8211;3 [in German].</li>

<li class="Ref">Scherak O, Kolarz G, Sch&#246;dl Ch, Blankenhorn G. Hochdosierte
Vitamin-E-Therapie bei Patienten mit aktivierter Arthrose. <em>Z Rheumatol</em>
1990;49:369&#8211;73 [in German].</li>

<li class="Ref">Brand C, Snaddon J, Bailey M, Cicuttini F. Vitamin E is ineffective for
symptomatic relief of knee osteoarthritis: a six month double blind, randomised, placebo
controlled study. <em>Ann Rheum Dis</em> 2001;60:946&#8211;9.</li>

<li class="Ref">Kaufman W. The use of vitamin therapy for joint mobility. Therapeutic reversal
of a common clinical manifestation of the &#8216;normal&#8217; aging process. <em>Conn State
Med J</em> 1953;17(7):584&#8211;9.</li>

<li class="Ref">Kaufman W. The use of vitamin therapy to reverse certain concomitants of
aging. <em>J Am Geriatr Soc</em> 1955;11:927.</li>

<li class="Ref">Hoffer A. Treatment of arthritis by nicotinic acid and nicotinamide. <em>Can
Med Assoc J</em> 1959;81:235&#8211;8.</li>

<li class="Ref">Jonas WB, Rapoza CP, Blair WF. The effect of niacinamide on osteoarthritis: a
pilot study. <em>Inflamm Res</em> 1996;45:330&#8211;4.</li>

<li class="Ref">Gibson SL, Gibson RG. The treatment of arthritis with a lipid extract of <em>
Perna canaliculus</em>: a randomized trial. <em>Comp Ther Med</em> 1998;6:122&#8211;6.</li>

<li class="Ref">Gibson RG, Gibson SL, Conway V, et al. Perna canaliculus in the treatment of
arthritis. <em>Practitioner</em> 1980;224L:955&#8211;9.</li>

<li class="Ref">Audeval B, Bouchacourt P. Double-blind, placebo-controlled study of the mussel
perna canaliculus (New Zealand green-lipped mussel) in gonarthrosis (arthritis of the knee).
<em>Gazette Med</em> 1986;93:111&#8211;5.</li>

<li class="Ref">Brooks PM. Side effects from Seatone. <em>Med J Aust</em> 1980;2:158
[letter].</li>

<li class="Ref">American Medical Association. Dimethyl sulfoxide. Controversy and Current
Status&#8212;1981. <em>JAMA</em> 1982;248:1369&#8211;71.</li>

<li class="Ref">Jimenez RA, Willkens RF. Dimethyl sulfoxide: a perspective of its use in
rheumatic diseases. <em>J Lab Clin Med</em> 1982;100:489&#8211;500.</li>

<li class="Ref">Eberhardt R, Zwingers T, Hofmann R. DMSO in patients with active gonarthrosis.
A double-blind placebo controlled phase III study. <em>Fortschr Med</em> 1995;113:446&#8211;50
[in German].</li>

<li class="Ref">Jacob SW, Wood DC. Dimethyl sulfoxide (DMSO). Toxicology, pharmacology, and
clinical experience. <em>Am J Surg</em> 114:414&#8211;26.</li>

<li class="Ref">Lawrence RM. Methylsulfonylmethane (MSM): a double-blind study of its use in
degenerative arthritis. <em>Int J of Anti-Aging Med</em> 1998;1:50.</li>

<li class="Ref">Siemandi H. The effect of cis-9-cetyl myristoleate (CMO) and adjunctive
therapy on arthritis and auto-immune disease: a randomized trial. <em>Townsend Letter for
Doctors and Patients</em> 1997;Aug/Sept:58&#8211;63.</li>

<li class="Ref">Newnham RE. The role of boron in human nutrition. <em>J Applied Nutr</em>
1994;46:81&#8211;5.</li>

<li class="Ref">Helliwell TR, Kelly SA, Walsh HP, et al. Elemental analysis of femoral bone
from patients with fractured neck of femur or osteoarthrosis. <em>Bone</em>
1996;18:151&#8211;7.</li>

<li class="Ref">Travers RL, Rennie GC, Newnham RE. Boron and arthritis: the results of a
double-blind pilot study. <em>J Nutr Med</em> 1990;1:127&#8211;32.</li>

<li class="Ref">Altman R, Gray R. Inflammation in osteoarthritis. <em>Clin Rheum Dis</em>
1985;11:353.</li>

<li class="Ref">Stammers T, Sibbald B, Freeling P. Fish oil in osteoarthritis. <em>Lancet</em>
1989;ii:503 [letter].</li>

<li class="Ref">Stammers T, Sibbald B, Freeling P. Efficacy of cod liver oil as an adjunct to
non-steroidal anti-inflammatory drug treatment in the management of osteoarthritis in general
practice. <em>Ann Rheum Dis</em> 1992;51:128&#8211;9.</li>

<li class="Ref">Balagot RC, Ehrenpreis S, Kubota K, Greenberg J. Analgesia in mice and humans
by D-phenylalanine: Relation to inhibition of enkephalin degradation and enkephalin levels.
In: Bonica JJ, Liebeskind JC, Albe-Fessard DG, eds., <em>Advances in Pain Research and
Therapy,</em> Vol 5. New York: Raven Press, 1983, 289&#8211;93.</li>

<li class="Ref">Budd K. Use of D-phenylalanine, an enkephalinase inhibitor, in the treatment
of intractable pain. In: Bonica JJ, Liebeskind JC, Albe-Fessard DG, eds., <em>Advances in Pain
Research and Therapy,</em> Vol 5. New York: Raven Press, 1983, 305&#8211;8.</li>

<li class="Ref">Walsh NE, Ramamurthy S, Schoenfeld LS, Hoffman J. Analgesic effectiveness of
D-phenylalanine in chronic pain patients. <em>Arch Phys Med Rehabil</em>
1986;67:436&#8211;9.</li>

<li class="Ref">Seltzer S, Marcus R, Stoch R. Perspectives in the control of chronic pain by
nutritional manipulation. <em>Pain</em> 1981;11:141&#8211;8 [review].</li>

<li class="Ref">Prudden JF, Balassa LL. The biological activity of bovine cartilage
preparations. <em>Semin Arthritis Rheum</em> 1974;3:287&#8211;320.</li>

<li class="Ref">Reijholec V. Long term studies of antiosteoarthritic drugs: an assessment.
<em>Semin Arthritis Rheum</em> 1987;17(2 Suppl 1):35&#8211;53.</li>

<li class="Ref">McCarthy GM, McCarty DJ. Effect of topical capsaicin in the therapy of painful
osteoarthritis of the hands <em>J Rheumatol</em> 1992;19:604&#8211;7.</li>

<li class="Ref">Altman RD, Aven A, Holmburg CE, et al. Capsaicin cream 0.025% as monotherapy
for osteoarthritis: a double-blind study. <em>Sem Arth Rheum</em> 1994;23(Suppl
3):25&#8211;33.</li>

<li class="Ref">Deal CL, Schnitzer TJ, Lipstein E, et al. Treatment of arthritis with topical
capsaicin: a double-blind trial. <em>Clin Ther</em> 1991;13:383&#8211;95.</li>

<li class="Ref">Schnitzer T, Morton C, Coker S. Topical capsaicin therapy for osteoarthritis
pain: achieving a maintenance regimen. <em>Sem Arth Rheum</em> 1994;23(Suppl
3):34&#8211;40.</li>

<li class="Ref">Schnitzer T, Morton C, Coker S. Topical capsaicin therapy for osteoarthritis
pain: achieving a maintenance regimen. <em>Sem Arth Rheum</em> 1994;23(Suppl
3):34&#8211;40.</li>

<li class="Ref">Deal CL. The use of topical capsaicin in managing arthritis pain: a
clinician&#8217;s perspective. <em>Sem Arth Rheum</em> 1994;23(Suppl 3):48&#8211;52.</li>

<li class="Ref">Mills SY, Jacoby RK, Chacksfield M, Willoughby M. Effect of a proprietary
herbal medicine on the relief of chronic arthritic pain: a double-blind study. <em>Br J
Rheum</em> 1996;35:874&#8211;88.</li>

<li class="Ref">Schmid B, Tschirdewahn B, K&#224;tter I, et al. Analgesic effects of willow
bark extract in osteoarthritis: results of a clinical double-blind trial. <em>Fact</em>
1998;3:186.</li>

<li class="Ref">Randall C, Meethan K, Randall H, Dobbs F. Nettle sting of <em>Urtica
dioica</em> for joint pain&#8212;an exploratory study of this complementary therapy. <em>Compl
Ther Med</em> 1999;7:126&#8211;31.</li>

<li class="Ref">Randall C, Randall H, Dobbs F, et al. Randomized controlled trial of nettle
sting for treatment of base-of-thumb pain. <em>J R Soc Med</em> 2000;93:305&#8211;9.</li>

<li class="Ref">REF: Srivastava KC, Mustafa T. Ginger (Zingiber officinale) in rheumatism and
musculoskeletal disorders. <em>Med Hypotheses</em> 1992;39:342&#8211;8.</li>

<li class="Ref">Bliddal H, Rosetzsky A, Schlichting P, et al. A randomized, placebo-controlled
crossover study of ginger extracts and ibuprofen in osteoarthritis. <em>Osteoarthritis
Cartilage</em> 2000;8:9&#8211;12.</li>

<li class="Ref">Altman RD, Marcussen KC. Effects of a ginger extract on knee pain in patients
with osteoarthritis. <em>Arthritis Rheum</em> 2001;44:2531&#8211;8.</li>

<li class="Ref">Chantre P, Cappelaere A, Leblan D, et al. Efficacy and tolerance of <em>
Harpagophytum procumbens</em> versus diacerhein in treatment of osteoarthritis. <em>
Phytomedicine</em> 2000;7:177&#8211;83.</li>

<li class="Ref">Safayhi H, Mack T, Saieraj J, et al. Boswellic acids: novel, specific,
nonredox inhibitors of 5-lipoxygenase. <em>J Pharmacol Exp Ther</em>
1992;261:1143&#8211;6.</li>

<li class="Ref">Kulkarni RR, Patki PS, Jog VP, et al. Treatment of osteoarthritis with a
herbomineral formulation: a double-blind, placebo-controlled, cross-over study. <em>J
Ethnopharmacol</em> 1991;33:91&#8211;5.</li>

<li class="Ref">Bingham R, Bellow BA, Bellow JG. Yucca plant saponin in the management of
arthritis. <em>J Appl Nutr</em> 1975;27:45&#8211;51.</li>

<li class="Ref">Piscoya J, Rodriguez Z, Bustamante SA, et al. Efficacy and safety of
freeze-dried cat's claw in osteoarthritis of the knee: mechanisms of action of the species
Uncaria guianensis. <em>Inflamm Res</em> 2001;50:442&#8211;8.</li>

<li class="Ref">Zeylstra H. <em>Filipendila ulmaria. Br J Phytotherapy</em>
1998;5:8&#8211;12.</li>

<li class="Ref">Rask MR. Colchicine use in five hundred patients with disk disease. <em>J
Neurol Orth Surg</em> 1980;1:1&#8211;19.</li>

<li class="Ref">Simmons JW, Harris WP, Koulisis CW, et al. Intravenous colchicine for low back
pain: A double blind study. <em>Spine</em> 1990;15:716&#8211;7.</li>

<li class="Ref">Gaw AC, Chang LW, Shaw L-C. Efficacy of acupuncture on osteoarthritic pain. A
controlled, double-blind study. <em>N Engl J Med</em> 1975;293:375&#8211;8.</li>

<li class="Ref">Takeda W, Wessel J. Acupuncture for the treatment of pain of osteoarthritic
knees. <em>Arthritis Care Res</em> 1994;7:118&#8211;22.</li>

<li class="Ref">Thomas M, Eriksson SV, Lundeberg T. A comparative study of diazepam and
acupuncture in patients with osteoarthritis pain: a placebo controlled study. <em>Am J Chin
Med</em> 1991;19:95&#8211;100.</li>

<li class="Ref">Christensen BV, Iuhl IU, Vilbek H, et al. Acupuncture treatment of severe knee
osteoarthrosis. A long-term study. <em>Acta Anaesthesiol Scand</em> 1992;36:519&#8211;25.</li>

<li class="Ref">Berman BM, Singh BB, Lao L, et al. A randomized trial of acupuncture as an
adjunctive therapy in osteoarthritis of the knee. <em>Rheumatology (Oxford)</em>
1999;38:346&#8211;54.</li>

<li class="Ref">Deyle GD, Henderson NE, Matekel RL, et al. Effectiveness of manual physical
therapy and exercise in osteoarthritis of the knee. A randomized, controlled trial. <em>Ann
Intern Med</em> 2000;132:173&#8211;81.</li>
</ol>
</div>
</body>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Osteoarthritis.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:30:17 GMT -->
</html>

